Patents by Inventor Marcus MUENZ

Marcus MUENZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T CELL ENGAGER MOLECULES AND USES THEREOF
    Publication number: 20250129160
    Abstract: The present invention provides single chain T cell engager (TCE) molecules having an scFab that binds a target antigen and an scFv that binds CD3, and TCE molecules that bind CCR8 and CD3. Methods of treating cancer are also provided.
    Type: Application
    Filed: June 2, 2022
    Publication date: April 24, 2025
    Applicants: AMGEN RESEARCH (MUNICH) GmbH, AMGEN INC.
    Inventors: Johannes BROZY, Christoph DAHLHOFF, Tobias RAUM, Jochen S. PENDZIALEK, Lisa WINKEL, Marcus MUENZ, Nathan William PIERCE, Agnieszka KIELCZEWSKA, Wentao CHEN, Darren L. BATES, Claudia BLUEMEL, Jonas Karl-Josef HONER